Drug
Topical minoxidil
Topical minoxidil is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_2
2
40%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Completed(1)
Detailed Status
Not yet recruiting2
Recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
N/A2 (40.0%)
Trials by Status
not_yet_recruiting240%
completed120%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia
NCT07536100
recruitingnot_applicable
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
NCT07373054
not_yet_recruitingphase_2
Various Procedural Treatment Options for Androgenetic Alopecia
NCT06826001
recruitingphase_1
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
NCT06333600
completedphase_2
Topical Cetirizine in Androgenetic Alopecia in Females
NCT04481412
Clinical Trials (5)
Showing 5 of 5 trials
NCT07536100Not Applicable
VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia
NCT07373054Not Applicable
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
NCT06826001Phase 2
Various Procedural Treatment Options for Androgenetic Alopecia
NCT06333600Phase 1
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
NCT04481412Phase 2
Topical Cetirizine in Androgenetic Alopecia in Females
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5